Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | HTR2A | P28223 | 2/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | RGS12 | O14924 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14541701 | 1.00 | CYP3A4 (0.53) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| SCHEMBL14224817 | 1.00 | CYP3A4 (0.53) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| Hydrochloric Acid SCHEMBL68364 | 0.98 | KMT2A (0.55) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| Acetic Acid SCHEMBL11356631 | 0.91 | ALDH1A1 (0.55) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| Pivalate SCHEMBL4575362 | 0.87 | ALDH1A1 (0.51) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| Mucic Acid SCHEMBL15509436 | 0.84 | ALDH1A1 (0.49) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| SCHEMBL9410650 | 0.82 | HTR2A (0.52) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| SCHEMBL354931 | 0.82 | ADRA2C (0.57) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| SCHEMBL14071918 | 0.82 | HTR2A (0.52) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A | |
| SCHEMBL7051224 | 0.82 | ADRA2C (0.52) | CYP3A4CYP2D6HTR2ACHRM2ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| CN-115901988-B | Construction method of magnolia bark ephedra Shang Zhiwen and standard fingerprint and application thereof | 神威药业集团有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119626580-A | Method for excavating key paths of traditional Chinese medicine pharmacodynamic substance groups and pharmacodynamic index groups based on PLS-SEM | 江西中医药大学 | 2025-03-14 | — | — | CN | claimed |
| CN-119574742-A | Method for detecting in-vivo prototype component in antiviral traditional Chinese medicine composition | 石家庄以岭药业股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| WO-2023192319-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-10-05 | — | — | WO | claimed |
| EP-3322482-B1 | TOPICAL CIPROFLOXACIN COMPOSITIONS | TAP PHARMACEUTICALS AG (CH) | 2023-07-26 | — | — | EP | claimed |
| WO-2023125519-A1 | NEW APPLICATION OF PLANT-DERIVED ALKALINE PHOSPHATASE EXPRESSION PROMOTER | 香港科技大学 | 2023-07-06 | — | — | WO | claimed |
| US-20230165836-A1 | ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER | Université Catholique de Louvain (BE) | 2023-06-01 | — | — | US | claimed |
| US-20230149360-A1 | ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS | Université Catholique de Louvain (BE) | 2023-05-18 | — | — | US | claimed |
| US-5429825-A | Mixing a powdered drug and excipients in a fluidized bed with countercurrent flow of gas and rotation | MCNEIL-PPC, INC. (US) | 1995-07-04 | — | — | US | claimed |
| EP-0294103-B1 | A sustained-release preparation and production thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-01-18 | — | — | EP | claimed |
| US-5368852-A | Prolonged-release liquid type of pharmaceutical preparation comprising drug-resin complex and benzoate preservative | ROHNTO PHARMACEUTICAL CO., LTD. (JP) | 1994-11-29 | — | — | US | claimed |
| US-5334378-A | Suspension consists of complex of ion exchange resin and active ingredient, thickening agent consists of natural gums, cellulose derivatives and alginates, amino acid or salt stabilizer and water | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 1994-08-02 | — | — | US | claimed |
| EP-0480934-B1 | A SLIMMING PHARMACEUTICAL COMPOSITION | NYCOMED DAK AS (DK) | 1994-06-29 | — | — | EP | claimed |
| EP-0582380-A1 | Dry granulation using a fluidized bed | McNEIL-PPC, INC. (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0565301-A1 | Prolonged-release liquid type of pharmaceutical preparation | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 1993-10-13 | — | — | EP | claimed |
| EP-0311383-B1 | MONOCLONAL ANTIBODY TO METHAMPHETAMINE, PREPARATION OF THE SAME, ASSAY METHOD AND ASSAY KIT OF METHAMPHETAMINE | UBE INDUSTRIES, LTD. (JP) | 1993-10-06 | — | — | EP | claimed |
| US-4894239-A | DRUG ADSORBED ON ION EXCHANGE RESIN | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-01-16 | — | — | US | claimed |
| EP-0294103-A1 | A sustained-release preparation and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-12-07 | — | — | EP | claimed |